Since its creation in 2002, the TAAM pole of Exploration by multimodality in vivo imaging has positioned itself as a national and European resource of imagery, at the service of biological, biomedical and pharmaceutical research.
A unique range of multimodal in vivo 2D or 3D imaging devices (radiology, radio-isotopic imaging, bioluminescence, fluorescence and photo-acoustic), makes possible finely tuned, non-invasive explorations in human pathology mouse models.
The Exploration by Imaging pole offers its scientific and technical skills in its specialist fields of murine model phenotyping, cancerology, infectiology, inflammation and drug vectorisation, to the scientific community of public or private researchers at large.
Depuis 2022, le secteur Imagerie in Vivo du TAAM fait partie de la plateforme MO2VING qui concentre de multiples expertises (IRM, RMN, MS, Imagerie et tri cellulaire) et propose une offre de service étoffée allant de la petite molécule au petit animal.
